Literature DB >> 10528781

Fusidic acid adverse drug reactions.

K Christiansen1.   

Abstract

Unlike trials conducted today on new antimicrobials, the introduction of fusidic acid was not accompanied by extensive studies on toxicity and side effects. The early studies on small numbers of patients reported fusidic acid to be a nontoxic drug with the main side effects being gastrointestinal tract discomfort, diarrhoea and headache. Case reports of hepatotoxicity were reported from 1972. A retrospective analysis showed this to be reversible and mainly associated with intravenous administration. Rarely reported side effects are granulocytopenia, thrombocytopenia and venous spasm. Skin reactions, including contact dermatitis, are uncommon. After many years of use the most common side effects reported for fusidic acid are minor and relate to the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528781     DOI: 10.1016/s0924-8579(98)00068-5

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  9 in total

Review 1.  Drug-induced immune thrombocytopenia.

Authors:  Patricia M L A van den Bemt; Ronald H B Meyboom; Antoine C G Egberts
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Flucloxacillin and fusidic acid-associated neutropenia in a patient with periaortic abscess: rare side effects of commonly used antibiotics.

Authors:  Negin Damali Amiri; Nishan Wijenaike
Journal:  BMJ Case Rep       Date:  2015-03-25

3.  PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections.

Authors:  Chiming Yang; David Plackett; David Needham; Helen M Burt
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

4.  Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Rong-mei Liang; Xiao-lan Yong; Yu-qin Duan; Yong-hong Tan; Ping Zeng; Zi-ying Zhou; Yan Jiang; Shi-hua Wang; Yun-ping Jiang; Xiao-chun Huang; Zhao-hui Dong; Ting-ting Hu; Hui-qing Shi; Nan Li
Journal:  World J Microbiol Biotechnol       Date:  2014-08-10       Impact factor: 3.312

Review 5.  Hepatotoxicity of antibacterials: Pathomechanisms and clinical.

Authors:  J M Leitner; W Graninger; F Thalhammer
Journal:  Infection       Date:  2010-01-27       Impact factor: 3.553

6.  Hypocalcaemia during fusidic acid therapy.

Authors:  M Biswas; K Owen; M K Jones
Journal:  J R Soc Med       Date:  2002-02       Impact factor: 18.000

7.  ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish.

Authors:  Carles Cornet; Simone Calzolari; Rafael Miñana-Prieto; Sylvia Dyballa; Els van Doornmalen; Helma Rutjes; Thierry Savy; Davide D'Amico; Javier Terriente
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

8.  Anaphylaxis to topically applied sodium fusidate.

Authors:  Mi-Ran Park; Do-Soo Kim; Jihyun Kim; Kangmo Ahn
Journal:  Allergy Asthma Immunol Res       Date:  2012-11-02       Impact factor: 5.764

9.  Bicytopenia in a 15-Year-Old Adolescent: A Rare Side Effect of Fusidic Acid.

Authors:  Nihan Şık; Kevser Asena Çakan Başerdem; Şefika Akyol; Özlem Tüfekçi; Durgül Yılmaz; Murat Duman
Journal:  Turk Arch Pediatr       Date:  2021-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.